A detailed history of Brewin Dolphin LTD transactions in Compass Pathways PLC stock. As of the latest transaction made, Brewin Dolphin LTD holds 10,600 shares of CMPS stock, worth $90,523. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,600
Previous 10,600 -0.0%
Holding current value
$90,523
Previous $137,000 16.06%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Nov 14, 2022

BUY
$21.81 - $48.96 $231,186 - $518,976
10,600 New
10,600 $234,000
Q3 2021

Nov 09, 2023

BUY
$29.03 - $38.62 $307,718 - $409,372
10,600 Added 30285.71%
10,635 $318 Million
Q4 2020

Nov 09, 2023

SELL
$32.0 - $59.2 $338,080 - $625,448
-10,565 Reduced 99.67%
35 $1.67 Million

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.